The Oncology Information Systems Market is projected to reach $4.45 billion by 2030, at a CAGR of 7.4% from 2023 to 2030. An oncology information system (OIS) is a software solution used to manage all aspects of cancer care, such as patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results. It differs from other types of information systems by its design and purpose, as it is specifically intended for managing cancer patients. It collects long-term patient data from patient history to various phases of treatments, diagnostic imaging, palliative care, and end-of-life care.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.
However, the high cost of oncology information systems and data security and privacy concerns are expected to restrain the growth of this market to a certain extent. In addition, factors such as barriers to adoption and implementation and additional requirement for training and education for using oncology information systems pose major challenges to the market’s growth.
Cancer has been one of the most complex and expensive diseases globally, with a huge economic burden on many countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetimes, with 1 in 8 men and 1 in 11 women dying from the disease.
Cancer is a major cause of death and a prominent obstacle to improving life expectancy in every country worldwide. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 million by 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million by 2030.
Early disease diagnosis and effective treatment can help decrease cancer mortality rates. As cancer treatment takes a long time, providing effective treatment can be improved by optimizing data collection and analysis. Oncology information systems support cancer care by collecting patient data during various stages of cancer care, including screening, prevention, diagnosis, treatment, palliative care, and end-of-life care. It helps streamline patient data and supports clinical decision-making. The rising prevalence of cancer is expected to drive the demand for oncology information systems.
Click here to: Get a Free Sample Copy of this Report
Rising Need to Reduce Oncology Care Costs to Drive Demand for Oncology Information Systems
The diagnosis, medication, and treatment for cancer is very costly since it requires treatment through surgery, radiotherapy, and chemotherapy. Owing to the high cost of cancer treatment, it causes an economic burden on countries. According to a study published in the JAMA Oncology journal, the global economic cost of cancers from 2020 to 2050 was estimated to be USD 25.2 trillion. The U.S. and China are estimated to face the largest economic burden of cancer. Hence, there is a rising need to reduce oncology care costs.
Oncology information systems can improve cancer care by improving documentation, optimizing resource allocation, and increasing cancer care's cost-effectiveness. Various professionals are involved in the care, such as oncologists, pathologists, radiologists, pharmacists, and laboratory technicians. Due to this, the adoption of oncology information systems reduces errors and increases data accuracy & efficiency through automating activities.
Thus, the rising need to reduce oncology care costs is expected to drive the demand for high adoption of oncology information systems in the coming years.
In 2023, the Software Segment is Expected to Dominate the Oncology Information Systems Market
Based on offerings, the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the largest share of the oncology information systems market. The large share of this segment is attributed to the factors such as the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
In 2023, the Medical Oncology Segment is Expected to Dominate the Oncology Information Systems Market
Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
In 2023, the Hospitals Segment is Expected to Dominate the Oncology Information Systems Market
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement an oncology information system, and increased number of cancer patients.
Asia-Pacific: The Fastest-growing Regional Market
Asia-Pacific is slated to record the highest CAGR in the oncology information systems market during the forecast period. The growth of this regional market is driven by the increasing number of oncology specialty hospitals, increasing awareness about health information systems (HIS), and increasing volume of patient data in the region.
Key Players
The report includes a competitive landscape based on an extensive assessment of the market based on offering, application, end user, and geography. The report also provides insights into the geographic presence of major market players and the key growth strategies adopted by them in the last three to four years.
The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Scope of the Report:
Oncology Information Systems Market Assessment, by Offering
Oncology Information Systems Market Assessment, by Application
Oncology Information Systems Market Assessment, by End User
Oncology Information Systems Market Assessment, by Geography
Key questions answered in the report:
This market study covers the market sizes & forecasts of the oncology information systems market based on offerings, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the oncology information systems market at the regional and country levels.
The oncology information systems market is projected to reach $4.45 billion by 2030, at a CAGR of 7.4% during the forecast period of 2023–2030.
Based on offerings, the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the largest share of the oncology information systems market due to increased demand for managing patient data, increased number of cancer cases, and rising need to reduce the cost of cancer care by making the process more efficient. The software segment is further segmented into patient information and treatment planning systems. The treatment planning systems segment is expected to register a higher CAGR due to increasing demand for integrated treatment planning across medical, radiology, and surgical oncology.
Based on application, the oncology information systems market is segmented into radiation oncology, medical oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market due to the large patient population requiring chemotherapy and increased demand from healthcare providers.
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the increasing number of patients visiting hospitals for cancer treatment and advanced infrastructure in hospitals to implement oncology information systems.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.
The high cost of oncology information systems and data security and privacy concerns are expected to restrain the growth of this market to a certain extent. In addition, factors such as barriers to adoption and implementation and additional requirement for training and education for using oncology information systems pose major challenges to the market’s growth.
The key players operating in the oncology information systems market are Accuray Incorporated (U.S.),
Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), Varian Medical Systems, Inc. (U.S.), and ViewRay Inc. (U.S.).
Asia-Pacific is slated to register the highest CAGR during the forecast period and offer significant growth opportunities for the players in this market. The growth of this regional market is driven by the increasing patient population, the ongoing development of healthcare infrastructure in the region, and increasing demand to streamline the rising patient data.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Cancer
4.2.2. Rising Digitalization in Cancer Treatment
4.2.3. Rising Need to Reduce Oncology Care Costs
4.2.4. Increasing Adoption of Electronic Health Records (EHRs)
4.2.5. Increased Demand for Streamlined Patient Information and Data Management
4.3. Restraints
4.3.1. High Cost of Oncology Information Systems
4.3.2. Data Security and Privacy Concerns
4.4. Opportunities
4.4.1. Integration of Precision Medicine for Cancer Treatment
4.4.2 Potential in Emerging Countries
4.5. Challenges
4.5.1. Barriers to Adoption and Implementation
4.5.2. Additional Requirement for Training and Education for Using Oncology Information Systems
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Case Studies
4.9. Industry & Technology Trends
5. Global Oncology Information Systems Market Assessment—by Offering
5.1. Overview
5.2. Software
5.2.1. Patient Information Systems
5.2.2. Treatment Planning Systems
5.3. Services
6. Global Oncology Information Systems Market Assessment—by Application
6.1. Overview
6.2. Radiation Oncology
6.3. Medical Oncology
6.4. Surgical Oncology
7. Global Oncology Information Systems Market Assessment—by End User
7.1. Overview
7.2. Hospitals
7.3. Diagnostic Imaging Centers
7.4. Cancer Care Centers
7.5. Other End Users
8. Oncology Information Systems Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Vendor Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Accuray Incorporated
10.2. Brainlab AG
10.3. DOSIsoft SA
10.4. Elekta AB
10.5. Koninklijke Philips N.V.
10.6. MIM Software Inc.
10.7. Oracle Corporation
10.8. Prowess Inc.
10.9. RaySearch Laboratories
10.10. Siemens Healthcare GmbH
10.11. ViewRay Inc.
10.12. McKesson Corporation
10.13. Altai, Inc.
(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Oncology Information Systems Market Drivers: Impact Analysis (2023–2030)
Table 2 Global Oncology Information Systems Market Restraints: Impact Analysis (2023–2030)
Table 3 Global Oncology Information Systems Market Opportunities: Impact Analysis (2023–2030)
Table 4 Global Oncology Information Systems Market Challenges: Impact Analysis (2023–2030)
Table 5 Global Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 6 Global Oncology Information Systems Software Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Oncology Information Systems Software Market, by Type, 2021–2030 (USD Million)
Table 8 Global Oncology Information Systems Services Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 10 Global Oncology Information Systems Market for Medical Oncology, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Oncology Information Systems Market for Radiation Oncology, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Oncology Information Systems Market for Surgical Oncology, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 14 Global Oncology Information Systems Market for Hospitals, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Oncology Information Systems Market for Diagnostic Imaging Centers, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Oncology Information Systems Market for Cancer Care Centers, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Oncology Information Systems Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Oncology Information Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 19 North America: Oncology Information Systems Market, by Country, 2021–2030 (USD Million)
Table 20 North America: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 21 North America: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 22 North America: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 23 North America: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 24 U.S.: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 25 U.S.: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 26 U.S.: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 27 U.S.: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 28 Canada: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 29 Canada: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 30 Canada: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 31 Canada: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 32 Europe: Oncology Information Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 33 Europe: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 34 Europe: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 35 Europe: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 36 Europe: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 37 Germany: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 38 Germany: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 39 Germany: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 40 Germany: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 41 U.K.: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 42 U.K.: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 43 U.K.: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 44 U.K.: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 45 France: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 46 France: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 47 France: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 48 France: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 49 Spain: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 50 Spain: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 51 Spain: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 52 Spain: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 53 Italy: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 54 Italy: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 55 Italy: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 56 Italy: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 57 Rest of Europe: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 58 Rest of Europe: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 59 Rest of Europe: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 60 Rest of Europe: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 61 Asia-Pacific: Oncology Information Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 62 Asia-Pacific: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 63 Asia-Pacific: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 64 Asia-Pacific: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 65 Asia-Pacific: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 66 China: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 67 China: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 68 China: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 69 China: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 70 Japan: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 71 Japan: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 72 Japan: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 73 Japan: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 74 India: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 75 India: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 76 India: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 77 India: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 78 Rest of Asia-Pacific: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 79 Rest of Asia-Pacific: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 80 Rest of Asia-Pacific: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 81 Rest of Asia-Pacific: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 82 Latin America: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 83 Latin America: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 84 Latin America: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 85 Latin America: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 86 Middle East & Africa: Oncology Information Systems Market, by Offering, 2021–2030 (USD Million)
Table 87 Middle East & Africa: Oncology Information Systems Market Software, by Type 2021–2030 (USD Million)
Table 88 Middle East & Africa: Oncology Information Systems Market, by Application, 2021–2030 (USD Million)
Table 89 Middle East & Africa: Oncology Information Systems Market, by End User, 2021–2030 (USD Million)
Table 90 Recent Developments, by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Oncology Information Systems Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global Oncology Information Systems Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 9 Global Oncology Information Systems Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 10 Global Oncology Information Systems Market, by Geography
Figure 11 Market Dynamics: Oncology Information Systems Market
Figure 12 Global Oncology Information Systems Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 13 Global Oncology Information Systems Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 14 Global Oncology Information Systems Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 15 Global Oncology Information Systems Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 16 North America: Oncology Information Systems Market Snapshot
Figure 17 Europe: Oncology Information Systems Market Snapshot
Figure 18 Asia-Pacific: Oncology Information Systems Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 20 Global Oncology Information Systems Market: Vendor Benchmarking Based on Application
Figure 21 Global Oncology Information Systems Market: Vendor Benchmarking Based on Geography
Figure 22 Global Oncology Information Systems Market: Competitive Dashboard
Figure 23 Market Share Analysis: Oncology Information Systems Market (2022)
Figure 24 Accuray Incorporated: Financial Overview (2022)
Figure 25 Brainlab AG: Financial Overview (2022)
Figure 26 Koninklijke Philips N.V.: Financial Overview (2022)
Figure 27 Elekta AB: Financial Overview (2022)
Figure 28 Oracle Corporation: Financial Overview (2022)
Figure 29 RaySearch Laboratories: Financial Overview (2022)
Figure 30 Siemens Healthcare GmbH: Financial Overview (2022)
Figure 31 McKesson Corporation: Financial Overview (2022)
Figure 32 Altai, Inc: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Feb-2023
Published Date: Jan-2023
Published Date: Jul-2022
Published Date: Oct-2018
